PacBio to Present at Upcoming Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PacBio (NASDAQ: PACB) announced management will participate in three investor conferences the week of November 18–19, 2025: Wolfe Research Healthcare Conference in New York, Jefferies Global Healthcare Conference in London, and Stephens Annual Investment Conference in Nashville.
Scheduled events include fireside chats on Nov 18 at 8:40 AM ET (Wolfe) and Nov 19 at 10:00 AM CT (Stephens); Jefferies meetings will be 1x1 sessions on Nov 19. Live webcasts of the fireside chats will be available at the company investor site, with replays available for at least 30 days.
Details
News Market Reaction – PACB
On Nov 14, the first trading day after this news, PACB closed 1.23% below the previous close.
Data tracked by StockTitan Argus for the Nov 14 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:
- Wolfe Research Healthcare Conference 2025 in New York, NY
Fireside chat on Tuesday, November 18 at 8:40 AM ET
- Jefferies Global Healthcare Conference in London, UK
Hosting 1x1 meetings only on Wednesday, November 19
- Stephens Annual Investment Conference in Nashville, TN
Fireside chat on Wednesday, November 19 at 10:00 AM CT
Live webcasts of the fireside chats can be accessed at the company's investors page at investor.pacificbiosciences.com. Webcast replays will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
ir@pacb.com
Media:
pr@pacb.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.